OPENPICHIA
LIVE

Serial Number

97867321

Owner

VIB VZW

Attorney

Clifford D. Hyra

Filing Date

Mar 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

OPENPICHIA Trademark

Serial Number: 97867321 • Registration: 7773262

OPENPICHIA is a trademark filed by VIB VZW on March 31, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VIB VZW (8 trademarks)

Suzanne Tassierstraat 1
Gent 9052 , BE

Entity Type: 99

Trademark Details

Filing Date

March 31, 2023

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, the food and animal feed industries, veterinary science, manufacturing of biological preparations, and in the field of industrial biotechnology; Natural science services, namely, scientific research and medical research in the fields of bacteriological, fungal, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services

Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals, and preparations in the nature of medicated wheat-free and gluten-free pasta, crackers for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Medical preparations and substances, namely, fungal preparations in the nature of fungal medications for medical purposes, probiotic preparations for medical use, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations and substances, namely, fungal preparations in the nature of fungal medications for veterinary purposes; Veterinary preparations in the nature of veterinary pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Biologicals preparations for medical and veterinary use, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Diagnostic and therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, diagnostic preparations for veterinary and medical use, pharmaceutical preparations and biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Cultures for pharmaceutical, medical and veterinary purposes, namely, diagnostic media for fungal cultures and cultures of microorganisms, all for medical or veterinary purposes; Preparations and substances for use in drug discovery, namely, sterilizing preparations, growth media preparations in the nature of cell growth media for growing cells for medical and veterinary purposes, and reagents and media for medical and veterinary diagnostic purposes, namely, such media and reagents serving as inoculate, clinical medical reagents, and diagnostic reagents

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 19, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2024 CNSA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 30, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 30, 2024 XELR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 30, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 31, 2024 GNFN
FINAL REFUSAL E-MAILED
May 31, 2024 GNFR
FINAL REFUSAL WRITTEN
May 31, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2023 NWOS
NEW APPLICATION ENTERED
Apr 4, 2023 NWAP